Clinical Trial

Observational, Non-interventional Biomarker and Endotyping Study

Study acronym: OBSERVE-ARDS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to establish a centralized ARDS biorepository of longitudinal biospecimens and harmonized clinical data, develop unsupervised, therapy-agnostic endotyping algorithms, and develop unsupervised, therapy-specific treatment-prediction algorithms over a 24 month period.
Trial Details
NCT Number NCT07675265
Lead Sponsor Prenosis, Inc.
Collaborators: Biomedical Advanced Research and Development Authority
Conditions ARDS (Acute Respiratory Distress Syndrome)
Enrollment 1,200 participants
Start Date 2026-07
Primary Completion 2028-12 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-30